Beam Therapeutics is trading 5.24% up now at $28.11 versus the August 12 close of $26.71; no fresh company-specific announcement explaining the August 13 pre-market move was found.
- The latest reported event was August 4 earnings, including a $1.18-per-share loss and $122.7 million net loss.
- That update is stale and does not clearly explain today’s move.
- Broader markets are nearly flat, offering limited support for a global explanation.